At least one in five people has obesity in each US state, data reveal

September 13, 2024 0 Comments 0 tags

Statistics from 2023 on U.S. obesity rates reveal that in every U.S. state, one in every five people now has obesity, according to data released Thursday by the U.S. Centers

Obesity treatments being restricted by cash poor local services across England, investigation finds

September 13, 2024 0 Comments 0 tags

Credit: Pixabay/CC0 Public Domain Patients in nearly half the country can’t get appointments with specialist teams for weight-loss support and care, including treatment with drugs such as semaglutide. And in

BMI’s relation to cancer therapy mortality risks not so straightforward, study finds

September 13, 2024 0 Comments 0 tags

For non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal for persons who might be overweight or

Semaglutide and tirzepatide lead to better blood sugar control and weight loss in type 1 diabetes, study finds

September 13, 2024 0 Comments 0 tags

Credit: Unsplash/CC0 Public Domain Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight

Analysis finds weight-loss surgery may help people with obesity manage high blood pressure

September 6, 2024 0 Comments 0 tags

Credit: Unsplash/CC0 Public Domain People with obesity who underwent weight-loss surgery were more likely to control their high blood pressure over a 1-to-5 year follow-period compared to those who managed

Mouse study reveals new central action target of weight loss drug GLP-1R agonists

September 6, 2024 0 Comments 0 tags

Graphical abstract. Credit: Journal of Clinical Investigation (2024). DOI: 10.1172/JCI178239 A research group led by Prof. Zhu Yingjie from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy